|
PDP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.41130457215399E-11 |
| Normal-vs-Stage2 |
1.10139999998093E-06 |
| Normal-vs-Stage3 |
3.22949999964628E-07 |
| Normal-vs-Stage4 |
1.90500999999177E-05 |
| Stage1-vs-Stage2 |
1.742250E-01 |
| Stage1-vs-Stage3 |
4.410500E-02 |
| Stage1-vs-Stage4 |
6.358800E-01 |
| Stage2-vs-Stage3 |
7.812600E-01 |
| Stage2-vs-Stage4 |
6.871000E-01 |
| Stage3-vs-Stage4 |
5.132400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.29960503364646E-11 |
| Normal-vs-Asian |
1.340380E-02 |
| Caucasian-vs-AfricanAmerican |
5.005600E-01 |
| Caucasian-vs-Asian |
6.149600E-01 |
| AfricanAmerican-vs-Asian |
5.436600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.38059588603323E-11 |
| Normal-vs-Female |
3.810396442816E-11 |
| Male-vs-Female |
5.040300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.46289980129666E-10 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
5.53910028955329E-10 |
| Normal-vs-Extreme_Obese |
3.71490000000696E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.218800E-01 |
| Normal_Weight-vs-Obese |
7.185000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.962200E-01 |
| Extreme_Weight-vs-Obese |
2.066200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.716400E-01 |
| Obese-vs-Extreme_Obese |
9.429200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.99900000008979E-07 |
| Normal-vs-Age(41-60Yrs) |
1.49379952851802E-10 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
3.71439999979906E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.547200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.329400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.432800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.078000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.849600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.616000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.02610142604931E-11 |
| Normal-VS-Type2 PRCC |
2.09259998218414E-09 |
| Normal-VS-KIRP CIMP |
1.357280E-04 |
| Normal-VS-Unclassified PRCC |
2.20450002696992E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.182700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.007800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.635500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.850800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.346200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.621800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24720234140341E-11 |
| Normal-vs-N1 |
1.56759999980771E-07 |
| Normal-vs-N2 |
5.409100E-04 |
| N0-vs-N1 |
2.881600E-01 |
| N0-vs-N2 |
5.252200E-01 |
| N1-vs-N2 |
1.931420E-01 |
|
|
